Literature DB >> 10666801

Principles of the diagnosis and antibiotic treatment of Lyme borreliosis.

F Strle1.   

Abstract

Clinical signs and symptoms are an essential aspect of the diagnosis of Lyme borreliosis. Thus, a thorough knowledge of the clinical features of the disease is important. Established clinical definitions could be of help in everyday clinical practice and especially to compare the findings of different authors or groups. The characteristic sign that permits the diagnosis of Lyme borreliosis is a typical erythema migrans skin lesion. Highly suggestive manifestations are ear lobe lymphocytoma, acrodermatitis chronica atrophicans and Bannwarth's syndrome. The majority of other signs and symptoms are only suggestive and, when expressed individually, may have a very limited or even symbolic value for the purpose of diagnosis. Laboratory confirmation of borrelial infection is needed, as a rule, for all manifestations of Lyme borreliosis with the exception of typical erythema migrans. In clinical practice indirect laboratory methods are usually employed. Determination of borrelial IgM and IgG antibodies by immunofluorescence assays or enzyme-linked immunosorbent assays has not been standardised, and correlation of the results from different laboratories and/or different commercial tests may be poor. Immunoblotting may solve some of the many dilemmas but could (especially in Europe) raise additional questions in a field in which numerous uncertainties already exist. The reliability of methods for direct detection of borrelial infection other than culture to ascertain spirochetes in tissue specimens is open to question. Treatment with antibiotics is reasonable in all stages of Lyme borreliosis and for all clinical manifestations; however, it has been most effective early in the course of the illness. The choice of antibiotic depends upon many factors including the efficacy, pharmacokinetic profile, side effects, expected compliance and price. For the majority of manifestations the most effective antibiotic, the optimal dosage, and the most appropriate duration of treatment have not been exactly determined. Recommendations for the treatment of Lyme borreliosis in Slovenia are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10666801

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  8 in total

1.  Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.

Authors:  Tjasa Cerar; Eva Ruzic-Sabljic; Joze Cimperman; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 2.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin.

Authors:  Tea Nizič; Eva Velikanje; Eva Ružić-Sabljić; Maja Arnež
Journal:  Wien Klin Wochenschr       Date:  2012-07-04       Impact factor: 1.704

4.  Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters.

Authors:  Emel Cetin; Mahtab Sotoudeh; Herbert Auer; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

5.  Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.

Authors:  Katarina Ogrinc; Mateja Logar; Stanka Lotric-Furlan; Dasa Cerar; Eva Ruzić-Sabljić; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 6.  Borrelial lymphocytoma.

Authors:  Vera Maraspin; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2022-08-09       Impact factor: 2.275

Review 7.  Opportunities and challenges to accurate diagnosis and management of acute febrile illness in adults and adolescents: A review.

Authors:  Brian S Grundy; Eric R Houpt
Journal:  Acta Trop       Date:  2021-12-23       Impact factor: 3.112

8.  Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme neuroborreliosis.

Authors:  T van Gorkom; W Voet; S U C Sankatsing; C D M Nijhuis; E Ter Haak; K Kremer; S F T Thijsen
Journal:  Clin Exp Immunol       Date:  2020-01-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.